openPR Logo
Press release

Bacterial Conjunctivitis Drugs Market: Rising Prevalence of MDROs Creates Serious Challenge for Market’s Growth

01-09-2017 01:37 PM CET | Health & Medicine

Press release from: TMR

Bacterial Conjunctivitis Drugs Market: Rising Prevalence

Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. Majority of the cases of bacterial conjunctivitis are self-limited and acute and not a major cause of morbidity. This study provides market analysis for various antibacterial drug classes used for the treatment of bacterial conjunctivitis. The stakeholders of this study comprise established pharmaceutical companies involved in the commercialization of antibacterial drugs as well as new participants who wish to enter the U.S. market.

View Exclusive Global Strategic Business Report:

This market study provides a complete analysis of the bacterial conjunctivitis drugs market in the U.S. and helps in identifying various market governing factors. The market overview section provides exhaustive information of the incidence rate of bacterial conjunctivitis, list of API manufacturers, patent challenges, market trends such as drivers, restraints, and growth opportunities that currently control the dynamics of the overall market. The section also recommends and predicts the future conditions of the market.

Market strategy tools such as event impact assessment and Porter’s Five Forces analysis have also been incorporated in this report to provide balanced analysis about the level of competition within the bacterial conjunctivitis drugs market in the U.S. Executive summary provided in the report encapsulates comprehensive insights about every segment considered in this study. Besides, it includes a market snapshot, which offers a glimpse into the current scenario of the bacterial conjunctivitis drugs market in the U.S. in terms of current and future market size along cumulative growth rate.

Additionally, this study includes a regulatory framework segment wherein the overall regulatory scenario of the U.S. drugs policy has been described. Participant analysis tools such as market share analysis have also been included in the market overview section of the report to deliver a broad spectrum of the overall market scenario in the bacterial conjunctivitis drugs market in the U.S.

The bacterial conjunctivitis drugs market in the U.S. has been segmented based on various antibacterial drug classes. The market is segmented into major types of antibacterial drugs such as fluoroquinolones, aminoglycosides, macrolides, and others. The fluoroquinolones segment has been sub-segmented into ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, gatifloxacin, and besifloxacin. Aminoglycosides has been sub-segmented into tobramycin and gentamycin.

Macrolides has been divided into erythromycin and azithromycin. The others segment is analyzed cumulatively, considering bacitracin, fusidic acid and ceftriaxone within this class. The market size for the period from 2012 to 2024 has been provided for each of the major drug classes mentioned above in terms of USD million. Along with the market size that were projected considering 2013 as the base year and 2012 as the historical year, the CAGR (%) of each market segment for the forecast period from 2012 to 2018 and 2018 to 2024 have also been provided.

The report concludes with detailed profiles of leading players in the bacterial conjunctivitis drugs (antibacterials) market in the U.S. The study profiles the companies in terms of overview, financial overview, product portfolio, business strategies, and recent developments. Major organizations profiled in this report include Actavis plc, Akorn, Inc., Bayer AG, F. Hoffmann-La Roche, Ltd., Merck & Co., Inc., Novartis AG, Perrigo Company plc, Pfizer, Inc., Santen Pharmaceutical Co., Ltd., and Valeant Pharmaceuticals International, Inc.

Browse Research Report:

Additionally, market share analysis that has been provided in context with the major pharmaceuticals operating in the market would help new participants to understand the key business perceptions and frameworks and to identify the specific product lines of the existing companies to establish a strong foothold in the bacterial conjunctivitis drugs market in the U.S.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Conjunctivitis Drugs Market: Rising Prevalence of MDROs Creates Serious Challenge for Market’s Growth here

News-ID: 408358 • Views: 310

More Releases from TMR

Anti-piracy Protection Market : Industry Analysis & Future Growth Prospects to 2 …
Anti-piracy protection is designed to prevent piracy, stop unauthorized access, and maximize monetization for media and IT software organizations. According to Steve Ragan, a security researcher at Akamai, "piracy is a never ending battle with no future-proof solution to address the issue online." Content developers are getting better at guarding against piracy, while criminals are using advanced techniques and skills to access the protected content. According to the MUSO data
Sales Enablement Software Market | Top Trends and Key Players Analysis Report 20 …
Sales enablement is the process of facilitating sales representatives with the right content, tools, knowledge, and information to help close a deal successfully. The right sales enablement content and tools enable sales reps to target the right customers and increase customer engagement. The sales enablement process helps accelerate sales, gather relevant data, and increase collaboration between teams to improve overall productivity. Sales enablement software provides data, resources, training, and visibility throughout
Digital Experience Monitoring (DEM) Market : Industry Development Scenario and F …
Digital experience monitoring (DEM) comprises a set of tools that measure digital experience and keep the software operating at peak performance. DEM software analyzes the efficiency and performance of applications and services. It is used to track, discover, and optimize web-based resources and end-user experience. DEM is the evolution of end-user experience monitoring and application performance monitoring tool into a holistic solution that analyzes the efficacy of an enterprise's applications and
Application Performance Monitoring (APM) Market - Segmentation, Major Players & …
The global application performance monitoring market was valued over US$ 5.9 Bn in 2021. It is estimated to grow at a CAGR of 12.1% from 2022 to 2031. The global application performance monitoring market is expected to exceed value of US$ 18.2 Bn by the end of 2031 Want to know the obstructions to your company's growth in future? Request a Sample @ Application performance monitoring (APM) is a software that

All 5 Releases